Article info
PDFEditorial commentary
Clinical course of MOG antibody-associated recurrent demyelinating diseases
- Correspondence to Professor Markus Reindl, Clinical Department of Neurology, Medical University of Innsbruck, Innsbruck A6020, Austria; markus.reindl{at}i-med.ac.at
Citation
Clinical course of MOG antibody-associated recurrent demyelinating diseases
Publication history
- Received September 25, 2017
- Accepted October 1, 2017
- First published November 24, 2017.
Online issue publication
January 15, 2018
Article Versions
- Previous version (24 November 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.